ChiCTR2300077609 版本V1.0 版本创建时间2023/11/14 11:17:40 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300077609 

最近更新日期:

Date of Last Refreshed on:

2023-11-14 11:17:36 

注册时间:

Date of Registration:

2023-11-14 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

孤独症谱系障碍儿童脑功能网络发育特征的差异性研究

Public title:

Study on differences in the developmental characteristics of brain functional networks in children with autism spectrum disorders

注册题目简写:

English Acronym:

研究课题的正式科学名称:

孤独症谱系障碍儿童脑功能网络发育特征的差异性研究

Scientific title:

Study on differences in the developmental characteristics of brain functional networks in children with autism spectrum disorders

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

马晨欢 

研究负责人:

马晨欢 

Applicant:

Chenhuan Ma 

Study leader:

Chenhuan Ma 

申请注册联系人电话:

Applicant telephone:

+86 134 5632 2250

研究负责人电话:

Study leader's
telephone:

+86 134 5632 2250

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

machenhuan@shchildren.com.cn

研究负责人电子邮件:

Study leader's E-mail:

machenhuan@shchildren.com.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市泸定路355号

研究负责人通讯地址:

上海市泸定路355号

Applicant address:

355 Luding Road, Shanghai, China

Study leader's address:

355 Luding Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市儿童医院

Applicant's institution:

Shanghai Children's Hospital

研究负责人所在单位:

上海市儿童医院

Affiliation of the Leader:

Shanghai Children's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023R007-F01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市儿童医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Children's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-16 00:00:00

伦理委员会联系人:

吕志宝

Contact Name of the ethic committee:

Zhibao Lv

伦理委员会联系地址:

上海市泸定路355号

Contact Address of the ethic committee:

355 Luding Road, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 5297 6581

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市儿童医院

Primary sponsor:

Shanghai Children's Hospital

研究实施负责(组长)单位地址:

上海市泸定路355号

Primary sponsor's address:

355 Luding Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市儿童医院

具体地址:

上海市泸定路355号

Institution
hospital:

Shanghai Children's Hospital

Address:

355 Luding Road, Shanghai, China

经费或物资来源:

上海市儿童医院

Source(s) of funding:

Shanghai Children's Hospital

研究疾病:

孤独症谱系障碍  

Target disease:

Autism Spectrum Disorder

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

本研究利用fNIRS技术构建ASD儿童和TD儿童脑功能网络,分析比较ASD儿童和TD儿童脑功能网络全局和局部效率的差异性,并将其作为特征性参数进一步探究有效区分ASD儿童和TD儿童的脑影像学指标,为ASD的早期诊断提供给影像学方面的客观且敏感指标。  

Objectives of Study:

Brain functional networks of children with ASD and children with TD were constructed by fNIRS technology in this study. The differences in global and local efficiency of brain functional networks of children with ASD and children with TD were analyzed and compared, and were taken as characteristic parameters to further explore the brain imaging indicators that can effectively distinguish children with ASD and children with TD, which cloud provide objective and sensitive indicators of imaging for early diagnosis of ASD.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

ASD 儿童: ① 根据《美国精神疾病分类与诊断手册第五版》(DSM-5)诊断为ASD的儿童; ② 年龄3~6岁; ③ Gesell量表DQ≥75或韦氏儿童智力量表(WISC)全量表智商≥70; ④ 第一语言为普通话; ⑤ 儿童家长愿意配合并遵守相关要求,并签署知情同意书。 TD 儿童: ① 年龄 3~6 岁; ② Gesell 量表 DQ≥75 或 WISC 全量表智商≥70; ③ 第一语言为普通话; ④ 儿童家长愿意配合并遵守相关要求,并签署知情同意书。

Inclusion criteria

ASD children: ① Children diagnosed with ASD according to DSM-5; ② Age 3-6 years old; ③ DQ of Gesell ≥75, or IQ of WISC ≥70; ④ The first language is Mandarin; ⑤ The parents of the children are willing to abide by the relevant requirements of the project and sign the informed consent. TD children: ① Age 3-6 years old; ② DQ of Gesell ≥75, or IQ of WISC ≥70; ③ The first language is Mandarin; ④ Parents of children are willing to cooperate and comply with relevant requirements, and sign an informed consent form.

排除标准:

① 儿童家长拒绝参与研究。

Exclusion criteria:

① The parents of children refuse to participate in the study.

研究实施时间:

Study execute time:

From 2023-04-01 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-06-01 00:00:00 To 2024-05-31 00:00:00

干预措施:

Interventions:

组别:

ASD组

样本量:

70

Group:

ASD group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

TD组(正常发育组)

样本量:

70

Group:

TD group (Typical development group)

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市儿童医院 

单位级别:

三级 

Institution
hospital:

Shanghai Children's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脑功能网络效率

指标类型:

主要指标

Outcome:

Efficiency of brain functional networks

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 3 years
最大 Max age 6 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Resman

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Resman

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF和S-Trial

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF and S-Trial

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-11-14 11:17:36